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NON-SPECIFIC tissue haemolysins have long been known to occur and the
haemolytic activity of normal tissue extracts has been extensively investigated
in attempts to explain normal in vivo red cell destruction (Maegraith, Martin and
Findlay, 1943; Laser, 1950; Ponder, 1951, 1952a). Comparison of the findings
from the majority of these studies is extremely complicated, however, because of
the use of a diversity oftissues and extraction procedures. Thus haemolysins have
been isolated in isotonic sodium chloride solutions either from freshly prepared
or pre-incubated tissue slices or minces (Weil, 1907; Maegraith, Martin and Find-
lay, 1943; Ponder, 1951), whilst others have used water miscible or immiscible
organic solvents such as ethanol and ether in the extraction procedures (Singer,
1940; Laser, 1950; Ponder, 1952b). Thehaemolyticactivitiesofextractsprepared
under such a variety of conditions obviously are not comparable and in many
cases, the haemolysins bear little or no relationship to one another. In general,
however, the water soluble haemolysins are less active than the lysins extracted
with ethanol or ether and it has been suggested that they exist as weakly active
lysin-inhibitor complexes (Ponder, 1951; Tyler, 1951).
Haemolytic material has also been isolated in fresh saline extracts of a number
of malignant tissues, particularly spontaneous, and transplanted mouse tumours
(Gross, 1948, 1949; Adelsberger, 1951; Ponder and Nesmith, 1952). Little is
yet known about the nature or properties of these haemolysins and considerable
disagreement still exists concerning their specificity. Thus, for example, Gross
(1948, 1949) claimed thathaemolytic activity was a specific property ofmalignant
tissues since species-specific haemolysins could be isolated from mouse and human
tumours but not from their normal tissues. In contrast, haemolysins have been
isolated under comparable conditions from normal adult and foetal guinea-pig
tissues (Tyler, 1951)andnormal mouselung (PonderandNesmith, 1952). Compari-
son of the data obtained in these studies, especially that of Ponder and Nesmith
(1952), reveals, however, thatmalignant tissueextracts generallyhave anincreased
haemolytic activity.
The survival of red cells from normal donors transfusedto cancer patients has
been extensively investigated during recent years (Sheets, Hamilton, De Gowin
and Janney, 1954; Hyman and Harvey, 1954; Miller, Chodos, Emerson and
Ross, 1956). These studies have shown that the life span of normal red cells is
shortened on transfusion into cancer patients and it has been proposed that a
humoral haemolytic factor plays an important role in the pathogenesis ofanaemia
incancer (HymanandHarvey, 1954). Morerecently, Hyman, Gellhorn andHarvey
(1956) have shown that red cells from cancer patients have normal or near normal
life spans when transfused into normal subjects indicating that there is noR. W. BALDWIN
intrinsic defect in the red cell and so further supporting the hypothesis of a cir-
culating haemolytic factor. Whether this haemolytic factor and the increased
haemolysin content of malignant tissue are related is still a matter for speculation.
At present, little is known about the nature of tissue haemolysins whilst it
still has to be shown that they can cause in vivo haemolysis. The present paper is
concerned with methods of isolation and assay of tissue haemolysins and a com-
parison of the haemolytic activities of normal and malignant rat tissue extracts.
Studies on the chemical and physical properties of rat tumour haemolysin will be
described in a later publication.
MATERIALS AND METHODS
Tumours
Transplanted rat sarcomata originally induced in inbred Wistar rats with
methylcholanthrene (Baldwin, 1955) were used as source of tumour tissue in most
of the experiments. These tumours (S5, S66, S69) were used between the 1st and
37th generation of transplantation. Experiments were also performed with the
Walker carcinoma and with two transplanted mouse tumours.
Preparation of tumour extracts
Initially when haemolysis tests were observed for periods up to 24 hours,
tumour extracts were prepared under sterile conditions. Later, however, tests
were observed for much shorter periods up to 5 hours and so no attempt was made
to ensure that extracts were sterile. Extracts from single tumours were used for
each test. The general technique utilized in the preparation of extracts was as
follows: Tumour was collected as quickly as possible under aseptic conditions
and transferred to an ice-cooled container. Portions of the healthy, peripheral
section of the tumour were then homogenized in an ice-cooled, vertical top drive,
blender (2-3 minutes at 13,000 r.p.m.) with 2 ml./g. wet weight of buffered
isotonic sodium chloride solution (0.14 M NaCl, 0.01 M NaH2PO4, 0.01 MNa2HPO4,
pH 6.8). Tumour homogenates were centrifuged immediately at 2000 G. and
5° C. and the supernatant fluids stored below 5° C. until tested for haemolytic
activity.
Initially, extracts were prepared in unbuffered isotonic NaCl solution. The
pH of these extracts varied considerably between pH 6.5 and 7.4 and later it was
shown that haemolytic activity was pH dependent; the activity rapidly decreas-
ing above pH 7.4. It was shown also that maximum haemolytic activity was
obtained between pH 6-5 and 6.8 and so extracts were prepared in lightly buffered
NaCl solution at pH 6.8. Extracts prepared in this medium had a pH range from
6.8 to 7*1.
Preparation of normal tissue extracts
Tests were performed on extracts of single organs and so the amount of tissue
available in some cases was small. In addition, simultaneous tests were performed
with extracts ofseveral organs from a single donor and so high-speed homogeniza-
tion was not used in the preparation of tissue extracts. Instead, organs were
removed from the donor as quickly as possible and transferred to weighed, ice-
cooled centrifuge bottles. The organs were then finely minced with scissors,
extracted with buffered NaCl solution, pH 6-8 (2 ml./g. wet weight of tissue)
630HAEMOLYSINS OF RAT TISSUES
and centrifuged 2000 G. and 5° C. The haemolytic activity of the supernatant
fluids was tested immediately following centrifugation.
Measurement of haemolysis
Red blood cells.-Blood of various species including rat, mouse, rabbit and
guinea pig was taken under sterile conditions either from a vein or from the heart
of anaesthetized animals and collected in heparinized isotonic NaCl solution
(0.14 M NaCl, 100 International units Heparin/ml.) Red cells were collected by
centrifugation (600 G. at 5° C.), washed three times with 0.14 M NaCl solution
and diluted in this medium to give a 1 per cent v./v. suspension. Sheep red cell
suspensions were prepared in a similar manner from sheep's blood obtained
commercially. Red cell suspensions were always freshly prepared and used within
6 hours of preparation.
Haemolysis test.-The haemolytic activity of an extract was determined by
measuring the time for complete haemolysis at 37° C. of a standard amount of
red cells by variousdilutions ofthe extract andconstructing a time-dilution curve.
From this curve, the activity of an extract was determined as the highest dilution
producing complete haemolysis in a standard time (usually 5 hours).
The haemolysis test was performed as follows:
Serial dilutions of extract in buffered NaCl solution (0.2 ml.) were maintained
at 37° C. ± 0-1° in a water bath and 1 per cent red cell suspension (0.1 ml.) at
the same temperature was added to each tube at a known time. The red cells
were thoroughly mixed with the extract and the time for complete haemolysis
determined.
RESULTS
Extracts of rat tumours were weakly active against rat red cells so that
haemolysis only occurred after incubation at 37° C. for 24 hours or longer (Table
I). Rat red cells, however, were readily agglutinated and most extracts caused
agglutination at dilutions of 1/32 following incubation at 37° C. for 5 hours. Only
extracts of the Walker carcinoma showed any appreciable haemolytic activity
for rat red cells and it should be noted that none of these extracts caused aggluti-
nation.
TABLE I.-Haemolysis and Haemagglutination of Rat Red Cells by Extracts of
Various Transplanted Tumours
Number producing Number producing
haemolysis haemagglutination
and maximum and maximum
Number of dilution titres* dilution titres*
extracts ,
Tumour tested 5 hours 24 hours 5 hours 24 hours
Rat-
Walker carcinoma . . 10 . 2 (32) 9 (32) . 0 0
Sarcoma:
S5 . 7 . 0 2 (4) . 7 (32) 7 (64)
S66 . . . 5 . 0 2 (4) . 5 (32) 5 (32)
S69 . . . . 2 . 0 1 (4) . 2 (32) 2 (32)
Mouse-
Strain A:
Mammary carcinoma . 5 . 0 5 (4) 5 (64) 5 (128)
*Figures in parentheses indicate reciprocals ofmaximum dilution titres.
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Rat tumour extracts were also haemolytic for the red cells of a sheep, rabbit
and guiuea-pig. Again, however, the haemolytic activity was low so that extracts
only produced haemolysis in one or two dilutions even after prolonged incubation.
In contrast, mouse red cells were very susceptible to haemolysis by rat tumour
haemolysin and in many cases, complete haemolysis was produced by extracts at
dilutions of 1/64 or greater following incubation for periods up to 5 hours. The
source of the mouse red cells appeared to have little influence on their suscepti-
bility to haemolysis and in experiments with mouse tumours, homologous red cells
were haemolysed as rapidly as red cells from other strains ofmice. Because oftheir
susceptibility totissuehaemolysin, mouseredcellshavebeenusedinthehaemolysis
test system in most experiments since they permit haemolytic titres to be deter-
mined within a convenient period of time.
Haemolysis ofmouse red cells by rat tumour extracts
Typical time-dilution curves for complete haemolysis of mouse red cells by
rat tumour extracts are shown in Fig. 1 (a, c). The form ofthese curves reveals the
presence ofan inhibitory zone at high concentrations ofextract so that on dilution,
o
o._ r- ._
FIG. 1.-Time-dilution curves for haemolysis of mouse red cells by transplanted rat tumour
extracts.
a and c.-Typical curves showing varying amounts of lysis inhibition at high concen-
trations of extract.
b.-Curve showing abnormal production of lysin during incubation of extracts.
the activity initially increases (haemolysis occurs more rapidly), passes through
a maximum and then decreases with further dilution. Inhibition zones at high
concentration were observed in all the tumour extracts tested although the amount
of inhibition varied considerably. In many cases, considerable inhibition was
obtained so that a definite maximum activity could be determined at some
dilution ofextract, usually in the range 1/4 to 1/16 (Fig. la). In other experiments,
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slight inhibition was obtained in only one or two dilutions of extracts so that the
inhibition zone appeared as a small infiexion on the time-dilution curve (Fig. lc).
The inhibitory factor revealed at high concentrations of extract makes direct
comparison of the activities of extracts extremely difficult. In previous studies
(Tyler, 1951), the time required for complete haemolysis of red cells by a single
arbitrarily fixed dilution of extract was used as a measure of haemolytic activity.
Obviously this measurement does not necessarily measure the true activity of
an extract since observations may be made in theinhibition zone. Determinations
of the percentage haemolysis produced by various dilutions of extract after an
arbitrarily fixed period oftime are alsounsatisfactory sincethe measurements may
fail to reveal the inhibitory zone, whilst observations after prolonged incubation
may be uncertain due to the production of fresh haemolysin from the incubated
extracts (Ponder, 1951; Ponder and Nesmith, 1952).
The activity of extracts can be determined, however, by observing the maxi-
mum dilution of extract producing complete haemolysis at regular intervals over
a period of time or preferably by determining the time required to produce
complete haemolysis by dilutions ofextract andconstructing atime-dilution curve.
Ifthe measurements are made for a sufficient period oftime, usually 3 to 5 hours,
a maximum dilution titre can be determined whilst observations of the rate of
haemolysis will indicate whether or not fresh haemolysin is being produced by
pre-incubation effects. Thus the activity of an extract expressed as the maximum
dilution producing complete haemolysis can be determined from the upper
asymptote of the time-dilution curve whilst the form of the curve indicates
whether or not lysin inhibitor is present and also whether pre-incubation effects
are occurring. In several experiments, an increase in the slope of the time-dilution
curve was observed after a certain period of time indicating an increase in the
rate of haemolysis due to abnormal production of lysin (Fig. lb). These results
have not been recorded since interpretation of the curves is difficult.
The maximum dilution titresforhaemolysis ofmousered cells byrat andmouse
tumour extracts are shown in Table II. All ofthe transplanted rat tumour extracts
were active against mouse red cells and the majority (72 per cent) had haemolytic
titres of 1/64 or 1/128. Extracts ofthe two transplanted mouse tumours included
TABLE II.-Haemolysis of Mouse Red Cells by Extracts of Various Transplanted
Tumours
Haemolytic titres.*
Number of extracts showing
Number of titres of
extracts A_,
Tumour tested. Range 4 8 16 32 64 128
Rat-
Walker carcinoma . 6 . 4-128 . 1 2 2
Sarcoma:
S5 . . . 6 . 4-128 . 1 - 2 2
S66 . . 15 . 32-128 . - - - 4 7 4
S69 . . . 10 . 8-128 . - 1 3 1 3 2
Mouse-
Strain C:
Sarcoma. . . 9 . 4-64 . 2 1 3 1 2
Strain A: .
Manmary carcinoma. 9 . 4-128 . 1 1 3 2 1 1
*Titres expressed as reciprocals ofmaximum dilution producing haemolysis.634 R. W. BALDWIN
for comparison had similar haemolytic titres although they were generally slightly
less active.
Haemolysis by extracts of normal rat tissues
Normal rat organ extracts were feebly active against rat red cells so that
haemolysis only occurred in dilutions up to 1/4 even after incubation at 37° C.
for 24 hours or longer. The extracts showed considerably more activity against
mouse red cells producing haemolysis at dilutions up to 1/64 following incubation
for 3 to 5 hours (Table III).
TABLE III.-Haemolytic Activity of Normal Rat Tissue Extracts Against Rat and
Mouse Red Cells
Number showing haemolysis
Number of at dilutions of:
extracts ^-A
Organ tested* 1/2 1/4 1/8 1/16 1/32 1/64
(a) Rat red cells: 24-hour titre
Liver. . 5/5 . 3 2 - - -
Lung. . 5/5 . 1 2 1 1 - -
Kidney . 1/5 . 1 . .
Spleen . 4/5 . 1 3 - - -
Heart . . 0/5
Serum . 0/5
(b) Mouse red cells: 5-hour titre
Liver. . 13/15 . - 2 7 4 -
Lung. . 15/15 . - 2 4 6 2 1
Kidney . 14/15 . - 3 3 8 -
Spleen . 15/15 . - - 1 3 8 3
Heart . 0/15
Serum . 0/15
* Numerator-Number of extracts causing haemolysis. Denominator-Number of extracts
tested.
All organ extracts, except those of heart tissue, possessed haemolytic activity,
However, serum inactivated at 56° C. was completely inactive even afterprolonged
incubation. Heating at 56° C. did not destroy the activity ofother tissue extracts.
Spleen extracts possessed the greatest activity although in two experiments,
lung extracts showed comparable activity. However, extracts of other organs
were generally 2 to 4 times less active than spleen extracts. The time-dilution
curves for complete haemolysis of mouse red cells by rat organ extracts (Fig. 2)
reveal that in additionto being the most active, spleen extractsproduce haemolysis
more rapidly than any other organ extract. Thus, the maximum dilution ofspleen
extract showing activity produces haemolysis in a much shorter time than any
of the other organ extracts at their maximum active dilution.
Inhibitory zones were again observed at high concentrations of organ extract
although the amount of inhibition generally was much lower than that detected
in tumour extracts. The amount ofinhibition produced by various organ extracts
also varied considerably, liver extracts showing the most and spleen extracts
the least.HAEMOLYSINS OF RAT TISSUES
DISCUSSION
The results indicate that haemolysins can be isolated in saline extracts of
normalrattissues aswellasfromtransplantedrattumourtissue. Thesehaemolysins
are not species-specific since under the right conditions, they will haemolyse the
red cells of several species. However, the mouse red cell appears to be very much
more susceptible to this type of haemolysin than any ofthe other red cells tested.
This mayexplainwhyinthe earlier studies (Gross, 1948), it was claimedthat mouse
tumour haemolysin was species-specific, since with an insensitive technique for
measuring haemolysis, red cells other than those of the mouse would appear to
o
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FIG. 2.-Typical time-dilution curves for haemolysis of mouse red cells by normal
rat organ extracts.
Spleen 0-0
Lung *-
Kidney X-X
Liver A-A
be resistant to the haemolysin. In fact the findings of Gross (1948) merely reflect
the relative susceptibility in vitro of the mouse red cell to this particular type of
haemolytic system. That varying red cell resistance series exist for different
haemolysins is illustrated by the findings of Howard and Wallace (1953) who
showed that the mouse red cell showed exceptional resistance to haemolysis by
streptolysin 0.
The relative resistance of rat red cells to haemolysis may be due to the fact
that they are readily agglutinated by the tissue extracts. This would have the
effectofmaking the red cells moreresistantto the haemolysin. Haemagglutination
activity has previously been observed by Salaman (1948) in extracts of a variety
of tumours against mouse and rabbit red cells and by Gross (1948) and Ponder
and Nesmith (1952) for rat and mouse tumour extracts against their homologous
red cells. As suggested byPonder andNesmith (1952), agglutinationandhaemolysis
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may be reciprocally related, the former occurring when the other does not and
vice versa. It is perhaps significant that extracts of the Walker carcinoma which
were much more haemolytic for rat red cells than any of the other rat tumour
extracts tested, caused no haemagglutination.
In confirmation of the findings of Ponder and Nesmith (1952), atypical time-
dilution curves were obtained for complete haemolysis of mouse red cells by both
normal and malignant rat tissue extracts (Fig. 1 and 2), indicating the presence of
an inhibitory factor athigh concentrations ofextract. Thisinhibitoryfactor makes
direct comparison ofthe activities of extracts extremely difficult, The haemolytic
activity of an extract can be expressed, however, as the maximum dilution
producing haemolysis of a standard amount of red cells under fixed conditions
oftime and temperature, providing that no abnormal lysin production is occurring.
This dilution titre will measure the maximum amount of haemolysin becoming
availablefromthe extractunderthe conditions usedandwilldependupon anumber
of competing factors such as the rates of inactivation of lysin and inhibitor and
the rate of lysin production or activation from inactive or slightly active lysin
complexes.
The haemolytic activities of various normal rat organ extracts were found to
vary considerably; spleen having the highest activity whilst serum and heart
extracts were inactive. Studies of the rates of haemolysis by organ extracts
indicated that in addition to being the most active, spleen extracts also produced
haemolysis most rapidly indicating that the lysin was more readily available
than that in other normal organ extracts. This may well be due to the absence of
inhibitory substances since spleen extracts rarely showed inhibitory zones in
time-dilution curves.
Comparison of the results obtained with extracts of normal and malignant
rat tissue extracts (Tables II and III) indicates that the haemolytic activity of
transplanted tumour extracts was generally 2 to 4 times greater than that of the
most active normal tissue extract, i.e. spleen. Since the haemolytic system in rat
tissue extracts consists of a mixture oflysins and inhibitors, the increased activity
of tumour extracts may be due to an actual increase in lysin or to a decrease in
inhibitor concentration. Although no quantitative data have been obtained
regarding the variations of inhibitor, comparison of the time-dilution curves for
haemolysis by extracts of normal organs; particularly spleen, and transplanted
tumours indicated that the more active tumour extracts also showed the most
inhibition. Thus, it would seem that there is an actual increase in the haemolysin
content of tumour extracts.
Attempts to obtain evidence relating tumour tissue haemolysins to a humoral
haemolytic factor so far have been unsuccessful since sera from tumour-bearing
animals have not shown any in vitro haemolytic activity. This is not surprising
however, since in the majority of previous studies on normal serum haemolysins,
active extracts couldonlybepreparedinnon-aqueous solvents anditwas suggested
that lysin-inhibitors may be responsible for the in vitro inactivity of whole serum
(Ponder, 1952b). These inhibitory substances are highly active in vitro and can
inhibit the activity of a variety ofhaemolysins, many ofwhich are far more active
than the naturally occurring tissue haemolysins (Ponder, 1952b; Stollerman,
1954). Therefore, it will be necessary to separate the naturally occurring serum
lysins from the inhibitors before any conclusive evidence can be obtainedregarding
the relationship between serum and tissue haemolysins.
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SUMMARY
1. Extracts of normal rat organs and transplanted tumours have been shown
to contain a water soluble haemolytic factor. These haemolysins were not species-
specific since they produced haemolysis of the red cells of several species including
rat, mouse, rabbit, guinea-pig and sheep. However, the mouse red cell was very
much more susceptible to the haemolysins than any of the other red cells tested.
Extracts were only weakly haemolytic against homologous rat red cells although
they readily caused haemagglutination.
2. Abnormal time-dilution curves for haemolysis of mouse red cells were
obtained with extracts ofboth normal andmalignant rat tissue extracts, indicating
the presence ofaninhibitory zone at high concentrations ofextract. It is concluded
that the haemolytic system consists of a mixture of lysins and inhibitors.
3. The haemolytic activity of normal tissue extracts varied considerably;
spleen showing the greatest activity whilst heart extracts and serum were inactive.
The haemolytic system in spleen extracts appears to be different from that ofother
normal tissue extracts. This is probably because spleen extracts contain little
or no lysin inhibitor.
4. The haemolytic activity of transplanted tumour extracts was usually 2 to 4
times greater than that of the most active normal tissue extract, i.e. spleen. This
increase in activity is probably due to an increase in haemolysin content rather
than to a decrease in inhibitor.
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